BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 14768953)

  • 21. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
    Biasiolo A; Rampazzo P; Brocco T; Barbero F; Rosato A; Pengo V
    Lupus; 1999; 8(2):121-6. PubMed ID: 10192506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
    Patsouras M; Tsiki E; Karagianni P; Vlachoyiannopoulos PG
    J Autoimmun; 2020 Dec; 115():102527. PubMed ID: 32709480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
    Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
    Zhao D; Ogawa H; Wang X; Cameron GS; Baty DE; Dlott JS; Triplett DA
    Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.
    Kolyada A; Porter A; Beglova N
    Blood; 2014 Feb; 123(7):1090-7. PubMed ID: 24277078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
    Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
    Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.
    Tanimura K; Jin H; Suenaga T; Morikami S; Arase N; Kishida K; Hirayasu K; Kohyama M; Ebina Y; Yasuda S; Horita T; Takasugi K; Ohmura K; Yamamoto K; Katayama I; Sasazuki T; Lanier LL; Atsumi T; Yamada H; Arase H
    Blood; 2015 Apr; 125(18):2835-44. PubMed ID: 25733579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis.
    Matsuura E; Kobayashi K; Kasahara J; Yasuda T; Makino H; Koike T; Shoenfeld Y
    Int Rev Immunol; 2002; 21(1):51-66. PubMed ID: 12187845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome.
    Amengual O; Atsumi T; Khamashta MA; Tinahones F; Hughes GR
    Br J Rheumatol; 1997 Sep; 36(9):964-8. PubMed ID: 9376992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome.
    Tinahones FJ; Cuadrado MJ; Khamashta MA; Mujic F; Gomez-Zumaquero JM; Collantes E; Hughes GR
    Br J Rheumatol; 1998 Jul; 37(7):746-9. PubMed ID: 9714350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
    Rauch J; Salem D; Subang R; Kuwana M; Levine JS
    Front Immunol; 2018; 9():2836. PubMed ID: 30619248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome.
    Kolyada A; Ke Q; Karageorgos I; Mahlawat P; Barrios DA; Kang PM; Beglova N
    J Thromb Haemost; 2016 Jun; 14(6):1298-307. PubMed ID: 26990752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.
    Artenjak A; Locatelli I; Brelih H; Simonič DM; Ulcova-Gallova Z; Swadzba J; Musial J; Iwaniec T; Stojanovich L; Conti F; Valesini G; Avčin T; Cohen Tervaert JW; Shoenfeld Y; Blank M; Ambrožič A; Sodin-Semrl S; Božič B; Čučnik S
    Immunol Res; 2015 Feb; 61(1-2):35-44. PubMed ID: 25395339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation.
    Matsuura E; Kobayashi K; Matsunami Y; Lopez LR
    Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between beta2-glycoprotein I valine/leucine247 polymorphism and anti-beta2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome.
    Atsumi T; Tsutsumi A; Amengual O; Khamashta MA; Hughes GR; Miyoshi Y; Ichikawa K; Koike T
    Rheumatology (Oxford); 1999 Aug; 38(8):721-3. PubMed ID: 10501418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.